PubMed

IGF binding protein 1 predicts cardiovascular morbidity and mortality in patients with acute myocardial infarction and type 2 diabetes.

Wallander M, Norhammar A, Malmberg K, Ohrvik J, Rydén L, Brismar K.

Diabetes Care. 2007 Sep;30(9):2343-8. Epub 2007 Jun 11.PMID: 17563335 [PubMed - indexed for MEDLINE]Related articlesFree article

Insulin-like growth factor I: a predictor of long-term glucose abnormalities in patients with acute myocardial infarction.

Wallander M, Brismar K, Ohrvik J, Rydén L, Norhammar A.

Diabetologia. 2006 Oct;49(10):2247-55. Epub 2006 Aug 29.PMID: 16955207 [PubMed - indexed for MEDLINE]Related articles

Prognostic implications of hypoglycaemic episodes during hospitalisation for myocardial infarction in patients with type 2 diabetes: a report from the DIGAMI 2 trial.

Mellbin LG, Malmberg K, Waldenström A, Wedel H, Rydén L; DIGAMI 2 investigators.

Heart. 2009 May;95(9):721-7. Epub 2008 Nov 24.PMID: 19029171 [PubMed - indexed for MEDLINE]Related articles

Intense metabolic control by means of insulin in patients with diabetes mellitus and acute myocardial infarction (DIGAMI 2): effects on mortality and morbidity.

Malmberg K, Rydén L, Wedel H, Birkeland K, Bootsma A, Dickstein K, Efendic S, Fisher M, Hamsten A, Herlitz J, Hildebrandt P, MacLeod K, Laakso M, Torp-Pedersen C, Waldenström A; DIGAMI 2 Investigators.

Eur Heart J. 2005 Apr;26(7):650-61. Epub 2005 Feb 23.PMID: 15728645 [PubMed - indexed for MEDLINE]Related articlesFree article

Asymmetric dimethylarginine predicts cardiovascular events in patients with type 2 diabetes.

Krzyzanowska K, Mittermayer F, Wolzt M, Schernthaner G.

Diabetes Care. 2007 Jul;30(7):1834-9. Epub 2007 Apr 24.PMID: 17456842 [PubMed - indexed for MEDLINE]Related articlesFree article

Hyperglycemia and compositional lipoprotein abnormalities as predictors of cardiovascular mortality in type 2 diabetes: a 15-year follow-up from the time of diagnosis.

Niskanen L, Turpeinen A, Penttilä I, Uusitupa MI.

Diabetes Care. 1998 Nov;21(11):1861-9.PMID: 9802734 [PubMed - indexed for MEDLINE]Related articlesFree article

Diabetes patients requiring glucose-lowering therapy and nondiabetics with a prior myocardial infarction carry the same cardiovascular risk: a population study of 3.3 million people.

Schramm TK, Gislason GH, Køber L, Rasmussen S, Rasmussen JN, Abildstrøm SZ, Hansen ML, Folke F, Buch P, Madsen M, Vaag A, Torp-Pedersen C.

Circulation. 2008 Apr 15;117(15):1945-54. Epub 2008 Mar 31.PMID: 18378618 [PubMed - indexed for MEDLINE]Related articlesFree article

Effects of pioglitazone on major adverse cardiovascular events in high-risk patients with type 2 diabetes: results from PROspective pioglitAzone Clinical Trial In macro Vascular Events (PROactive 10).

Wilcox R, Kupfer S, Erdmann E; PROactive Study investigators.

Am Heart J. 2008 Apr;155(4):712-7. Epub 2008 Feb 21. Erratum in: Am Heart J. 2008 Aug;156(2):255. PMID: 18371481 [PubMed - indexed for MEDLINE]Related articles

Low levels of insulin-like growth-factor-binding protein-1 (IGFBP-1) are prospectively associated with the incidence of type 2 diabetes and impaired glucose tolerance (IGT): the Söderåkra Cardiovascular Risk Factor Study.

Petersson U, Ostgren CJ, Brudin L, Brismar K, Nilsson PM.

Diabetes Metab. 2009 Jun;35(3):198-205. Epub 2009 Mar 17.PMID: 19297224 [PubMed - indexed for MEDLINE]Related articles

High insulinlike growth factor binding protein 1 level predicts incident congestive heart failure in the elderly.

Kaplan RC, McGinn AP, Pollak MN, Kuller L, Strickler HD, Rohan TE, Cappola AR, Xue X, Psaty BM.

Am Heart J. 2008 Jun;155(6):1006-12. Epub 2008 Mar 5.PMID: 18513511 [PubMed - indexed for MEDLINE]Related articles

Association of total insulin-like growth factor-I, insulin-like growth factor binding protein-1 (IGFBP-1), and IGFBP-3 levels with incident coronary events and ischemic stroke.

Kaplan RC, McGinn AP, Pollak MN, Kuller LH, Strickler HD, Rohan TE, Cappola AR, Xue X, Psaty BM.

J Clin Endocrinol Metab. 2007 Apr;92(4):1319-25. Epub 2007 Jan 30.PMID: 17264182 [PubMed - indexed for MEDLINE]Related articlesFree article

Glycometabolic state at admission: important risk marker of mortality in conventionally treated patients with diabetes mellitus and acute myocardial infarction: long-term results from the Diabetes and Insulin-Glucose Infusion in Acute Myocardial Infarction (DIGAMI) study.

Malmberg K, Norhammar A, Wedel H, Rydén L.

Circulation. 1999 May 25;99(20):2626-32.PMID: 10338454 [PubMed - indexed for MEDLINE]Related articlesFree article

Leptin: a predictor of abnormal glucose tolerance and prognosis in patients with myocardial infarction and without previously known Type 2 diabetes.

Wallander M, Söderberg S, Norhammar A.

Diabet Med. 2008 Aug;25(8):949-55.PMID: 18959608 [PubMed - indexed for MEDLINE]Related articles

Elevated plasma homocysteine level is an independent predictor of coronary heart disease events in patients with type 2 diabetes mellitus.

Soinio M, Marniemi J, Laakso M, Lehto S, Rönnemaa T.

Ann Intern Med. 2004 Jan 20;140(2):94-100.PMID: 14734331 [PubMed - indexed for MEDLINE]Related articlesFree article

Total insulinlike growth factor 1 and insulinlike growth factor binding protein levels, functional status, and mortality in older adults.

Kaplan RC, McGinn AP, Pollak MN, Kuller L, Strickler HD, Rohan TE, Xue X, Kritchevsky SB, Newman AB, Psaty BM.

J Am Geriatr Soc. 2008 Apr;56(4):652-60. Epub 2008 Feb 27.PMID: 18312313 [PubMed - indexed for MEDLINE]Related articles

Insulin-like growth factor-binding protein-1 in the prediction and development of type 2 diabetes in middle-aged Swedish men.

Lewitt MS, Hilding A, Ostenson CG, Efendic S, Brismar K, Hall K.

Diabetologia. 2008 Jul;51(7):1135-45. Epub 2008 May 22.PMID: 18496669 [PubMed - indexed for MEDLINE]Related articles

The prospective association of serum insulin-like growth factor I (IGF-I) and IGF-binding protein-1 levels with all cause and cardiovascular disease mortality in older adults: the Rancho Bernardo Study.

Laughlin GA, Barrett-Connor E, Criqui MH, Kritz-Silverstein D.

J Clin Endocrinol Metab. 2004 Jan;89(1):114-20.PMID: 14715837 [PubMed - indexed for MEDLINE]Related articlesFree article

Reduced IGFBP-1 is associated with thickening of the carotid wall in type 2 diabetes.

Leinonen ES, Salonen JT, Salonen RM, Koistinen RA, Leinonen PJ, Sarna SS, Taskinen MR.

Diabetes Care. 2002 Oct;25(10):1807-12.PMID: 12351482 [PubMed - indexed for MEDLINE]Related articlesFree article

Association of serum levels of IGF-I and IGFBP-1 with renal function in patients with type 2 diabetes mellitus.

Akturk M, Arslan M, Altinova A, Ozdemir A, Ersoy R, Yetkin I, Ayvali E, Gonen S, Toruner F.

Growth Horm IGF Res. 2007 Jun;17(3):186-93. Epub 2007 Feb 27.PMID: 17329141 [PubMed - indexed for MEDLINE]Related articles

Risk factors for cardiovascular mortality and morbidity: the WHO Mutinational Study of Vascular Disease in Diabetes.

Fuller JH, Stevens LK, Wang SL.

Diabetologia. 2001 Sep;44 Suppl 2:S54-64.PMID: 11587051 [PubMed - indexed for MEDLINE]Related articles